Edelweiss' research report on CCL Products
CCL Products India’s (CCL) Q4FY18 revenue and EBITDA at INR3.2bn and INR712mn came below our INR3.6bn and INR821mn estimates, respectively. This was on account of lower India business revenue as supply of agglomerated coffee started from Vietnam. However, APAT at INR472mn came in line with estimate as tax rate was lower at 24% versus 31% estimated and 33% in Q4FY17. Management has guided for 10-20% volume growth without factoring the impact of freeze dried capacity expansion (to be commissioned in Sept 2018). Our FY19 numbers are ahead of management’s estimates as we factor in the benefit of the capacity’s commissioning.
Outlook
Maintain ’BUY’ with TP of INR437 based on 24x FY20E EPS. Timely commissioning of the freeze dried capacity is key monitorable.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.